Hepatic resection for colorectal liver metastases

Area of Science:

• Surgical Oncology
• Hepatobiliary Surgery
• Gastrointestinal Oncology

Background:

• Colorectal liver metastases (CLM) are a common and often fatal complication of colorectal cancer.
• Hepatic resection is a potentially curative treatment for CLM, offering significant long-term survival benefits.
• Careful patient selection and surgical technique are paramount for optimal outcomes.

Purpose of the Study:

• To outline the indications, contraindications, and surgical considerations for hepatic resection in patients with CLM.
• To emphasize the importance of preoperative assessment and intraoperative imaging.
• To discuss the role of different resection types and adjuvant therapies.

Main Methods:

• Review of current literature and guidelines regarding surgical management of CLM.
• Description of preoperative evaluation protocols, including imaging and staging.
• Explanation of surgical techniques, including intraoperative ultrasound and classification of resections (anatomic vs. segmental).

Main Results:

• Hepatic resection can achieve a 5-year survival rate of 25-35% for selected patients with CLM.
• Contraindications include positive lymph nodes, extrahepatic disease, and numerous lesions (≥4).
• Segmental resections are often preferred due to reduced complications and improved efficiency.

Conclusions:

• Hepatic resection is a vital treatment modality for colorectal liver metastases.
• Thorough preoperative assessment and intraoperative ultrasound are essential to guide surgical decisions.
• Systemic chemotherapy is necessary for patients who develop extrahepatic disease post-resection to improve overall survival.